Greenridge Global downgrades Flexible Solutions Intl (AMEX:FSI) from Buy to Hold.
SpringWorks Therapeutics Highlights Presentation Of Updated Data From Phase 2b ReNeu Trial At Children’s Tumor Foundation Conference
Additional Follow-up of First 20 Adult Patients Enrolled Continues to Show Encouraging Efficacy and Tolerability of Mirdametinib in Patients with NF1-PN
STAMFORD, Conn., June 15, 2021 (GLOBE NEWSWIRE) -- SpringWorks